Bone Void Filler for overseas market
ReBOSSIS
For more information >
The world’s first cotton-shaped artificial bone filler with bioactivity evidenced by ISO23317 that went on sale in the United States in February 2015. “It is characterized by high bone shape performance, good bioabsorbability, and ease of processing.”
The number of cases of trauma and orthopedic surgery in the spinal area has already exceeded 8,000 (as of August 2021) and has attracted the attention of many orthopedic surgeons.
*Bioactivity has not been evaluated in clinical trials.
The number of cases of trauma and orthopedic surgery in the spinal area has already exceeded 8,000 (as of August 2021) and has attracted the attention of many orthopedic surgeons.
*Bioactivity has not been evaluated in clinical trials.
Combination of ReBOSSIS and syringe
“Pursuing ease of use and minimal invasiveness”
“Pursuing ease of use and minimal invasiveness”
Bone Void Filler for Japanese market
For Orthopedic Surgery
For Maxillofacial and Plastic Surgery
For Neurosurgery, Maxillofacial and Plastic Surgery
Cell Culture Materials
Stem Cell Culture/Extract Sheet
For more information >
For More Efficiency & Cost Reduction
“Best Fruit of our Bioabsorbable Fiber Technology.”
“Best Fruit of our Bioabsorbable Fiber Technology.”
